(VIANEWS) – Agnico Eagle Mines Limited (AEM), Edwards Lifesciences (EW), LeMaitre Vascular (LMAT) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Agnico Eagle Mines Limited (AEM)
13.1% sales growth and 13.96% return on equity
Agnico Eagle Mines Limited engages in the exploration, development, and production of mineral properties in Canada, Mexico, and Finland. The company operates through Northern Business and Southern Business segments. It primarily produces and sells gold deposit, as well as explores for silver, zinc, and copper deposits. The company's flagship property is the LaRonde mine located in the Abitibi region of northwestern Quebec, Canada. As of December 31, 2019, its LaRonde mine had a mineral reserve of approximately 2.9 million ounces of gold. The company is also involved in exploration activities in Europe, Latin America, and the United States. Agnico Eagle Mines Limited was founded in 1953 and is headquartered in Toronto, Canada.
Earnings Per Share
As for profitability, Agnico Eagle Mines Limited has a trailing twelve months EPS of $5.18.
PE Ratio
Agnico Eagle Mines Limited has a trailing twelve months price to earnings ratio of 10.37. Meaning, the purchaser of the share is investing $10.37 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.96%.
Sales Growth
Agnico Eagle Mines Limited’s sales growth is 19.4% for the current quarter and 13.1% for the next.
Volume
Today’s last reported volume for Agnico Eagle Mines Limited is 4959860 which is 85.83% above its average volume of 2669020.
Yearly Top and Bottom Value
Agnico Eagle Mines Limited’s stock is valued at $53.70 at 14:22 EST, way under its 52-week high of $61.15 and way above its 52-week low of $43.22.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Nov 29, 2023, the estimated forward annual dividend rate is 1.6 and the estimated forward annual dividend yield is 2.98%.
2. Edwards Lifesciences (EW)
7.7% sales growth and 22.06% return on equity
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides the PASCAL and Cardioband transcatheter valve repair systems for minimally-invasive therapy. In addition, it offers surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; KONECT RESILIA, a pre-assembled aortic tissue valved conduit for patients who require replacement of the valve, root, and ascending aorta; and HARPOON Beating Heart Mitral Valve Repair System for patients with degenerative mitral regurgitation. Further, the company provides critical care solutions, including advanced hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
Earnings Per Share
As for profitability, Edwards Lifesciences has a trailing twelve months EPS of $2.34.
PE Ratio
Edwards Lifesciences has a trailing twelve months price to earnings ratio of 29.18. Meaning, the purchaser of the share is investing $29.18 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 22.06%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 12.3%, now sitting on 5.82B for the twelve trailing months.
Yearly Top and Bottom Value
Edwards Lifesciences’s stock is valued at $68.27 at 14:22 EST, way under its 52-week high of $94.87 and way higher than its 52-week low of $60.57.
3. LeMaitre Vascular (LMAT)
7.1% sales growth and 9.92% return on equity
LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude the blood flow; perfusion catheters to perfuse the blood and other fluids into the vasculature; and thrombectomy catheters, which features a silicone balloon for removing thrombi in the venous system. The company also provides carotid shunts that temporarily shunt the blood to the brain during the removal of plaque from the carotid artery in a carotid endarterectomy surgery; powered phlebectomy devices to remove varicose veins; and radiopaque tape, a medical-grade tape applied to the skin that enables interventionists to cross-refer between the inside and the outside of a patient's body, and allows them to locate tributaries or lesions beneath the skin. In addition, it offers remote endarterectomy devices to remove plaque from arteries in the leg; valvulotomes, which cut valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and vascular grafts to bypass or replace diseased arteries. Further, the company provides vascular patches, which are used for closure of vessels after surgical intervention; closure systems to attach vessels to one another with titanium clips instead of sutures; and surgical glue. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.
Earnings Per Share
As for profitability, LeMaitre Vascular has a trailing twelve months EPS of $1.22.
PE Ratio
LeMaitre Vascular has a trailing twelve months price to earnings ratio of 43.63. Meaning, the purchaser of the share is investing $43.63 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.92%.
Moving Average
LeMaitre Vascular’s worth is higher than its 50-day moving average of $52.02 and below its 200-day moving average of $56.41.
4. Kirby Corporation (KEX)
6.7% sales growth and 6.46% return on equity
Kirby Corporation operates domestic tank barges in the United States. Its Marine Transportation segment provides marine transportation services and towing vessels transporting bulk liquid products, as well as operates tank barges throughout the Mississippi River System, on the Gulf Intracoastal Waterway, coastwise along three United States coasts, and in Alaska and Hawaii. This segment also transports petrochemicals, black oil, refined petroleum products, and agricultural chemicals by tank barges; and operates offshore dry-bulk barge and tugboat units that are engaged in the offshore transportation of dry-bulk cargoes in the United States coastal trade. As of December 31, 2019, this segment owned and operated 1,053 inland tank barges with 23.4 million barrels of capacity, 299 inland towboats, 49 coastal tank barges with 4.7 million barrels of capacity, 47 coastal tugboats, 4 offshore dry-bulk cargo barges, 4 offshore tugboats, and 1 docking tugboat. The company's Distribution and Services segment sells replacement parts; provides service mechanics to overhaul and repair engines, transmissions, reduction gears, and related oilfield services equipment; rebuilds component parts or diesel engines, transmissions and reduction gears, and related equipment used in oilfield services, marine, power generation, on-highway, and other industrial applications; rents industrial compressors, railcar movers, and high capacity lift trucks; and manufactures and remanufactures oilfield service equipment, including pressure pumping units. It serves oilfield service, on-highway transportation, marine transportation, commercial fishing, construction, and power generation companies, as well as oil and gas operators and producers, and the United States government. The company was formerly known as Kirby Exploration Company, Inc. and changed its name to Kirby Corporation in 1990. Kirby Corporation was founded in 1921 and is headquartered in Houston, Texas.
Earnings Per Share
As for profitability, Kirby Corporation has a trailing twelve months EPS of $3.3.
PE Ratio
Kirby Corporation has a trailing twelve months price to earnings ratio of 23.13. Meaning, the purchaser of the share is investing $23.13 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.46%.
Volume
Today’s last reported volume for Kirby Corporation is 275807 which is 22.36% below its average volume of 355257.
Sales Growth
Kirby Corporation’s sales growth is 6.6% for the ongoing quarter and 6.7% for the next.
Yearly Top and Bottom Value
Kirby Corporation’s stock is valued at $76.34 at 14:22 EST, way under its 52-week high of $87.52 and way higher than its 52-week low of $60.14.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Kirby Corporation’s EBITDA is 1.9.
5. Navigator Holdings Ltd. Ordinary Shares (NVGS)
6.5% sales growth and 6.55% return on equity
Navigator Holdings Ltd. owns and operates a fleet of liquefied gas carriers worldwide. It provides international and regional seaborne transportation services of petrochemical gases, liquefied petroleum gases, and ammonia for energy companies, industrial users, and commodity traders. The company also offers ship shore infrastructure and consultancy services. It operates a fleet of 56 semi- or fully-refrigerated liquefied gas carriers. The company was formerly known as Isle of Man public limited company and changed its name to Navigator Holdings Ltd. in 2006. Navigator Holdings Ltd. was incorporated in 1997 and is headquartered in London, the United Kingdom.
Earnings Per Share
As for profitability, Navigator Holdings Ltd. Ordinary Shares has a trailing twelve months EPS of $0.99.
PE Ratio
Navigator Holdings Ltd. Ordinary Shares has a trailing twelve months price to earnings ratio of 14.22. Meaning, the purchaser of the share is investing $14.22 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.55%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 128.6% and 32%, respectively.
Volume
Today’s last reported volume for Navigator Holdings Ltd. Ordinary Shares is 96353 which is 33.68% below its average volume of 145301.
Yearly Top and Bottom Value
Navigator Holdings Ltd. Ordinary Shares’s stock is valued at $14.08 at 14:22 EST, below its 52-week high of $15.21 and way higher than its 52-week low of $11.09.
Sales Growth
Navigator Holdings Ltd. Ordinary Shares’s sales growth is 1% for the current quarter and 6.5% for the next.
6. OFG Bancorp (OFG)
5.5% sales growth and 17.39% return on equity
OFG Bancorp, a financial holding company, provides a range of banking and financial services. It operates through three segments: Banking, Wealth Management, and Treasury. The company offers checking and savings accounts, as well as time deposit products; commercial, consumer, auto leasing, and mortgage lending services; financial planning and insurance services; and corporate and individual trust, and retirement services. In addition, it provides securities brokerage and investment advisory services, including various investment alternatives, such as tax-advantaged fixed income securities, mutual funds, stocks, and bonds to retail and institutional clients; and separately-managed accounts and mutual fund asset allocation programs. Further, the company engages in the insurance agency and reinsurance businesses; administration and servicing of retirement plans; various treasury-related functions with an investment portfolio consisting of mortgage-backed securities, obligations of U.S. government sponsored agencies, and U.S. Treasury securities and money market instruments; and management and participation in public offerings and private placements of debt and equity securities. Additionally, it offers money management and investment banking services; and engages in the asset/liability management activities, such as purchases and sales of investment securities, interest rate risk management, derivatives, and borrowings. OFG Bancorp was founded in 1964 and is headquartered in San Juan, Puerto Rico.
Earnings Per Share
As for profitability, OFG Bancorp has a trailing twelve months EPS of $3.81.
PE Ratio
OFG Bancorp has a trailing twelve months price to earnings ratio of 8.73. Meaning, the purchaser of the share is investing $8.73 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.39%.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is a negative 4.1% and a negative 6.2%, respectively.
Volume
Today’s last reported volume for OFG Bancorp is 114416 which is 41.78% below its average volume of 196550.
Revenue Growth
Year-on-year quarterly revenue growth grew by 4%, now sitting on 625.86M for the twelve trailing months.
